ÂÜÀòÂÒÂ×

Alan Stephen Harris serves as the Chairman of the Board for Amzell BV, a biotech company located in the Netherlands, and Bazell Pharma AG, a drug delivery company in Basel, both since January 2020. Additionally, Alan is a Board Member of RADEPT, an NGO focused on enhancing access to medications in Africa, particularly in Rwanda, and a Board Member of Glucox Biotech AB, a biotechnology firm in Stockholm, since January 2018. Alan has held the position of Senior Vice President for Research and Development at Ferring Pharmaceuticals since January 1984, overseeing global R&D initiatives and Branded Life Cycle Management programs from the company's headquarters in Switzerland.